Table 5.

Risk factors for biopsy specimen–proven acute rejection after kidney transplant in recipients with polycystic kidney disease

Variable	Hazard Ratio (95% CI)		P Value
Age (per decade)	0.79 (0.62 to 1.01)		0.06
Female sex	1.64 (1.07 to 2.50)		0.02a
Non-White race	1.26 (0.65 to 2.47)		0.49
BMI (per 1 kg/m2 higher BMI)	1.04 (1.01 to 1.08)		0.02a
Dialysis before transplantation	1.27 (0.79 to 2.10)		0.33
Dialysis duration	1.00 (0.99 to 1.01)		0.82
Coronary artery disease	2.37 (1.47 to 3.84)		<0.001a
Congestive heart failure	0.74 (0.32 to 1.72)		0.48
Polycystic liver disease	1.25 (0.79 to 1.84)		0.39
Deceased donor	0.92 (0.59 to 1.44)		0.72
Donor age	1.00 (0.85 to 1.16)		0.96
Prior kidney transplantation	2.59 (1.38 to 4.87)		0.003a
Induction treatment
Basiliximab	Reference
Thymoglobulinb	0.82 (0.45 to 1.49)		0.50
Alemtuzumab	1.38 (0.81 to 2.33)		0.23
Other	0.13 (0.03 to 0.62)		0.01a
None	0.64 (0.19 to 2.14)		0.46
Calcineurin-inhibitor maintenance
Tacrolimus	Reference
Cyclosporine	0.86 (0.53 to 1.37)		0.52
None	1.79 (0.97 to 3.32)		0.06a
Mycophenolate maintenance	0.33 (0.14 to 0.73)		0.006a
HLA mismatch
0–2	Reference
3–4	2.30 (1.21 to 4.37)		0.01a
5–6	4.07 (2.10 to 7.92)		<0.001a
Nephrectomy at transplantation	1.17 (0.74 to 1.84)		0.49

BMI, body mass index.

^aP<0.05.

^bRabbit anti-thymocyte globulin.